Latest Updates

Patient & caregiver survey for Opdivo™ (nivolumab)

A new kidney cancer therapy Opdivo™ (nivolumab) is undergoing assessment by the pan-Canadian Oncology Drug Review (pCODR). As part of the review process, registered patient groups such as Kidney Cancer Canada are invited to provide input so that patients and caregivers can be heard. More information and to participate in the survey on this link. click here

Posted January 20, 2016

Our Treatment Access by Province/Territory document has been updated. Click here

Posted January 18, 2016

Our Clinical Trials List has been updated. Click here

Posted January 18, 2016

The Kidney Cancer Canada Nurses Network is a members-only protected site. Healthcare professionals are encouraged to apply for membership by clicking here


Upcoming Meetings - Save the Date!

Kidney Cancer Canada
2016 Patient & Caregiver Forum

Where: Sheraton Centre Toronto Hotel, Toronto, ON

When: March 5, 2016

This meeting is for patients, caregivers and all health care professionals.

Registration & details on this link.